Skip to Content

John FitzGerald

The growing availability of biologic therapies for rheumatoid arthritis and other inflammatory autoimmune disorders has had a dramatic impact on the treatment and prognosis for patients with these potentially disabling diseases. Biologics are genetically engineered drugs designed to interact with the body’s immune response [...]
By uclahealth • August 3, 2016